The 18th International congress on Myelodysplastic Syndrome (MDS 2025) is a conference dedicated to the the latest developments in the Myelodysplastic Syndrome field.
Topics
- Diagnosis (flow cytometry, morphology and molecular)
- Clinical Management
- Pathogenesis (immunological, molecular, animal models and cellular)
- Epidemiology (quality of life, demographics and co-morbidity)
- Prognostic Factors and Models
- Childhood MDS
- Stem Cell Transplantation
- Supportive Care including Iron Chelation Therapy
- Therapy (low-risk MDS and high-risk MDS)
Who should Attend
Scientists and educators working with MDS and hematology to discuss quality of life, long-term care and longevity of patients suffering from this debilitating disease.
